دورية أكاديمية

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer.

التفاصيل البيبلوغرافية
العنوان: Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer.
المؤلفون: Ramalingam, Suresh S., Spigel, David R., Chen, David, Steins, Martin B., Engelman, Jeffrey A., Schneider, Claus-Peter, Novello, Silvia, Eberhardt, Wilfried E. E., Crino, Lucio, Kai Habben, Lian Liu, Jaänne, Pasi A., Brownstein, Carrie M., Reck, Martin
المصدر: Journal of Clinical Oncology; 12/1/2011, Vol. 29 Issue 34, p4574-4580, 7p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2011.36.6799